![[D] Transcript of speech by Agnes Buzyn on compulsory vacciantion](/uploads/r/null/b/c/f/bcf0d94ed4cc1c0ab27f47667ae5f243a1df018a08cc2802d60233bc82f9a254/ca028c6b-5d90-4b3e-9e67-a80a09a89b10-_D__solidarites-sante-gouv-fr-actualites-presse-discours-article-discours-d-agnes-buzyn-relatif-a-la-vaccination-obligatoire-le-5-juillet-2017-2021-02-09-11_21_13_142.jpg)
Pièce
·
05/07/2017
Fait partie de UoA 10
Transcript of speech by Agnes Buzyn on compulsory vacciantion
Sans titre![[E] Extension of French vaccination mandates: from the recommendation of the Steering Committee of the Citizen Consultation on Vaccination to the law](/uploads/r/null/6/b/2/6b220ac5f7162e138027f28ec82f9426be48ea87ef5cd6c59621d941555ebf6a/9b89e49e-b0ca-4563-abeb-afe3c45cde25-_E__eurosurv-23-17-3_142.jpg)
![[Avi]WHO Global Tuberculosis Report 2020.pdf](/uploads/r/null/a/7/2/a7272980f4195b530a5d7340685e4d4e602a372c4d177ad5d94e5f94252b4954/9dc9e24e-f053-49c6-98cf-1abc2ad4d65c-_Avi_WHO_Global_Tuberculosis_Report_2020_142.jpg)
![[B] Roadmap towards ending TB in children and adolescents.pdf](/uploads/r/null/9/8/4/984e1d28ba570f203624105fdf3b2947fcc5642ea9ad6c22f53a2c89fa8a86f4/d5ae07b3-beeb-46e9-a3e0-9c907375003f-_B___Roadmap_towards_ending_TB_in_children_and_adolescents_142.jpg)
![[D] National Tuberculosis Control Programme, Bangladesh.pdf](/uploads/r/null/6/9/8/698862bdb81040e70113c2252eeb6fd0610730764272fa3b09e3d6e64f2a2b25/0d69721f-def8-46cc-92df-64a5a666724a-_D__National_Tuberculosis_Control_Programme__Bangladesh_142.jpg)
![[H] Research Priorities for Paediatric Tuberculosis. World Health Organization.pdf](/uploads/r/null/c/e/6/ce6978c0663c33ae536b6fe183964389d4426b8acdf5b0caab2a07c6fadf0da8/b2cbceb9-89a9-4dbf-8f38-facb3e3066c2-_H__Research_Priorities_for_Paediatric_Tuberculosis._World_Health_Organization_142.jpg)
![[I] Best Practices in Child and Adolescent TB Care.pdf](/uploads/r/null/7/a/e/7ae3332acb450662fdb56da88a8dc9fad3daec705dafb6c92f9012e26fa8ac69/959f42f8-08b5-476d-9ad1-7d30978fd5b0-_I__Best_Practices_in_Child_and_Adolescent_TB_Care_142.jpg)
![[C] dnanudgecomenCOVID-Nudge .pdf](/uploads/r/null/8/0/b/80b809a34a9d39f84c9a0ca181e04586a88627db1fbbb67a9716f3407929ea26/fc33ca2d-e743-4b9d-8b42-5fc88f0b6418-_C__dnanudgecomenCOVID-Nudge__142.jpg)
![[G] New post-polypectomy and post-colorectal cancer resection surveillance guidelines.pdf](/uploads/r/null/4/1/a/41a9142a3c79962620c7fa59870b3b64d459bc089c971c3d99473bc15098fc36/7917aa94-2fcc-4fb0-8fd5-530a94363dd3-_G__New_post-polypectomy_and_post-colorectal_cancer_resection_surveillance_guidelines_142.jpg)
![[D] Carrick Therapeutics Press announces first patient on CT7001 30th Nov 2017.pdf](/uploads/r/null/f/f/d/ffda5c3a4f4c68f44f65e474e112a266e2803f92ccf4b171cdfa225656c0046e/5e03e674-eb70-4c02-b12a-fa2b260f1f54-_D__Carrick_Therapeutics_Press_announces_first_patient_on_CT7001_30th_Nov_2017_142.jpg)
![[A] RCOG guideline addendum .pdf](/uploads/r/null/a/2/c/a2c8fb3f30504281fec4addebb611050f27f6ab6a5fe44cc0d482d0d70562ec4/f5792b22-e73f-4544-a807-59582d6a679f-_A__RCOG_guideline_addendum__142.jpg)
![[H] The All Party Parliamentary Group on Baby Loss.pdf](/uploads/r/null/1/8/e/18ee6342cc31eaaad9d481ff790c045ebe81dd8b6e7791f7ea5954a046b6833e/e228f059-11b4-4b1c-af4e-cf51bbf55fa3-_H__The_All_Party_Parliamentary_Group_on_Baby_Loss_142.jpg)
![[Jii] The Guadian Share your experiences of how early miscarriage impacted on your mental health.pdf](/uploads/r/null/c/e/6/ce6c5ca359e7b7d92d0bb3a7ae6ebf8f2eec58f12f5f046e014cb449d5cb67a7/bb06a03f-edcc-4d40-97a2-70ddab08d84c-_Jii__The_Guadian_Share_your_experiences_of_how_early_miscarriage_impacted_on_your_mental_health_142.jpg)
![[I] ADNEX risk model.pdf](/uploads/r/null/4/9/0/490ac1e578d19013c3c2e4ec28ab37c85e6385e74e3e30ba118ed5fe346b5777/dacf8216-6e29-4371-a8bd-e4816004efd7-_I__ADNEX_risk_model_142.jpg)
![[Ei] UK Health Service Commissioning.pdf](/uploads/r/null/2/6/a/26afc5d8068ca0049c04fd2487741e6172f4544ebb4ebaaa95d1d7734b692d77/ce77c157-7e52-4df0-8872-8105cefe27e5-_Ei__UK_Health_Service_Commissioning_142.jpg)
![[I] EMA Summary of opinion Kalydeco.pdf](/uploads/r/null/6/9/f/69f5b6684c69eaf2ab9e4e024465979536dc4a61a3e03362c92a9472a7406f5e/77efc402-d85b-4c97-9d44-b53f7a027c7e-_I__EMA_Summary_of_opinion_Kalydeco_142.jpg)
![[A] Minutes of the Joint Committee On Vaccination And Immunisation, June 2015 meeting.pdf](/uploads/r/null/5/6/6/5667e282d67f49a3c3a7e7069618ea68ce1f62d22bc5a56f3b60ea17ed12a316/9f823ef7-d7c8-4a8b-a091-9dc47df50441-_A__Minutes_of_the_Joint_Committee_On_Vaccination_And_Immunisation__June_2015_meeting_142.jpg)
![[B] Public Health England. Influenza the green book, chapter 19.pdf](/uploads/r/null/f/0/2/f02373715027f475550905e29933c20a48890ae4750d1048a2c6d27f56f797fa/870c9132-fced-443c-9a5e-39a3d801b09a-_B__Public_Health_England._Influenza_the_green_book__chapter_19_142.jpg)
![[B] Endobronchial valve insertion to reduce lung volume in emphysema. Interventional procedures guidance [IPG600].pdf](/uploads/r/null/4/f/9/4f96a8289da6f409bd8bf7ed529fe34629561e478478a522224d23fca6f592df/343d76db-5d94-405f-b1b5-0a0dc914b4ba-_B__Endobronchial_valve_insertion_to_reduce_lung_volume_in_emphysema._Interventional_procedures_guidance__IPG600__142.jpg)
![[J] The World Health Organization. Guidelines on Hepatitis B and C testing.pdf](/uploads/r/null/8/c/7/8c7cbdc7ca28cce45e2dcfb5d6b68165b4a88c6c573e0ba9a695a31c587a29c4/4882be05-3926-48b7-bcac-3f7bf6d461bf-_J__The_World_Health_Organization._Guidelines_on_Hepatitis_B_and_C_testing_142.jpg)